Primary Care Clinics in Camden On Gauley, WV Accepting Medicare
1 Primary Care Clinics found. Showing 1 - 1
 Camden On Gauley Medical Center Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 10003 Webster Rd, Camden On Gauley, WV 26208 Phone: 304-226-5725 Fax: 304-226-3274 |
News Archive
Multivitamin use linked to less healthy behaviors
The lack of evidence on multivitamin health benefits is no impediment to their widespread popularity, with over half the U.S. population popping such pills. This translates into a $27 billion industry, which lures consumers with the illusory promise of better health. But shocking new research suggests taking multivitamins might have the opposite effect - not simply on the metabolic level, but on a metaphysical one: promoting a false sense of invulnerability that actually leads users to engage in riskier behaviors.
Gray's Anatomy: Grey area for medical students!
In a new study researchers have found that Australian medical students are struggling to name important body parts. They found that only nine of the 26 students could answer half of 20 questions correctly. Some (nearly a quarter) answers were "of concern" indicating a perfunctory knowledge of human anatomy.
Scientists measure distraction
A scientific indicator of how easily distracted you are has been designed by a UCL (University College London) psychologist. It could be used as another assessment tool during the recruitment process and would have particular benefits in fields where employee distraction could lead to fatal errors.
Women with a recent diagnosis of cancer in one breast should have MRI screening of the opposite breast
The international research team found that MRI, or magnetic resonance imaging, detected cancer in the opposite breast in 30 of 969 women (3.1 percent) who had recently been diagnosed with cancer in one breast only. The cancers in the opposite breast were missed by previous mammography and clinical exam.
Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
› Verified 1 days ago